143 related articles for article (PubMed ID: 37140233)
1. IMPA2 blocks cervical cancer cell apoptosis and induces paclitaxel resistance through p53-mediated AIFM2 regulation.
Xie K; Liu L; Wang M; Li X; Wang B; Yin S; Chen W; Lin Y; Zhu X
Acta Biochim Biophys Sin (Shanghai); 2023 Apr; 55(4):623-632. PubMed ID: 37140233
[TBL] [Abstract][Full Text] [Related]
2. A novel function of IMPA2, plays a tumor-promoting role in cervical cancer.
Zhang K; Liu L; Wang M; Yang M; Li X; Xia X; Tian J; Tan S; Luo L
Cell Death Dis; 2020 May; 11(5):371. PubMed ID: 32409648
[TBL] [Abstract][Full Text] [Related]
3. ATF6 aggravates acinar cell apoptosis and injury by regulating p53/AIFM2 transcription in Severe Acute Pancreatitis.
Tan JH; Cao RC; Zhou L; Zhou ZT; Chen HJ; Xu J; Chen XM; Jin YC; Lin JY; Zeng JL; Li SJ; Luo M; Hu GD; Yang XB; Jin J; Zhang GW
Theranostics; 2020; 10(18):8298-8314. PubMed ID: 32724472
[No Abstract] [Full Text] [Related]
4. Cyclin-dependent kinase 9 promotes cervical cancer development via AKT2/p53 pathway.
Xu J; Xu S; Fang Y; Chen T; Xie X; Lu W
IUBMB Life; 2019 Mar; 71(3):347-356. PubMed ID: 30536701
[TBL] [Abstract][Full Text] [Related]
5. Role of activating transcription factor 3 on TAp73 stability and apoptosis in paclitaxel-treated cervical cancer cells.
Oh YK; Lee HJ; Jeong MH; Rhee M; Mo JW; Song EH; Lim JY; Choi KH; Jo I; Park SI; Gao B; Kwon Y; Kim WH
Mol Cancer Res; 2008 Jul; 6(7):1232-49. PubMed ID: 18644986
[TBL] [Abstract][Full Text] [Related]
6. The inhibitory effect of MEG3/miR-214/AIFM2 axis on the growth of T-cell lymphoblastic lymphoma.
Fan FY; Deng R; Yi H; Sun HP; Zeng Y; He GC; Su Y
Int J Oncol; 2017 Jul; 51(1):316-326. PubMed ID: 28534937
[TBL] [Abstract][Full Text] [Related]
7. Sensitivity of ASPP and P-gp to neoadjuvant chemotherapy combined with gene therapy in locally advanced cervical cancer.
Xiao J; Zhou J; Liang L; Liu F; Liang H; Xu C; Meng J
J BUON; 2019; 24(3):967-974. PubMed ID: 31424649
[TBL] [Abstract][Full Text] [Related]
8. AIFM2 blocks ferroptosis independent of ubiquinol metabolism.
Dai E; Zhang W; Cong D; Kang R; Wang J; Tang D
Biochem Biophys Res Commun; 2020 Mar; 523(4):966-971. PubMed ID: 31964528
[TBL] [Abstract][Full Text] [Related]
9. Regulation of p53 expression and apoptosis by vault RNA2-1-5p in cervical cancer cells.
Kong L; Hao Q; Wang Y; Zhou P; Zou B; Zhang YX
Oncotarget; 2015 Sep; 6(29):28371-88. PubMed ID: 26318295
[TBL] [Abstract][Full Text] [Related]
10. Metformin induces apoptosis and inhibits migration by activating the AMPK/p53 axis and suppressing PI3K/AKT signaling in human cervical cancer cells.
Chen YH; Yang SF; Yang CK; Tsai HD; Chen TH; Chou MC; Hsiao YH
Mol Med Rep; 2021 Jan; 23(1):. PubMed ID: 33236135
[TBL] [Abstract][Full Text] [Related]
11. Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma.
Lin YF; Chou JL; Chang JS; Chiu IJ; Chiu HW; Lin YF
EBioMedicine; 2019 Jul; 45():220-230. PubMed ID: 31202813
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of the mammalian target of rapamycin (mTOR) by rapamycin increases chemosensitivity of CaSki cells to paclitaxel.
Faried LS; Faried A; Kanuma T; Nakazato T; Tamura T; Kuwano H; Minegishi T
Eur J Cancer; 2006 May; 42(7):934-47. PubMed ID: 16540312
[TBL] [Abstract][Full Text] [Related]
13. Prognostic and predictive roles of microRNA‑411 and its target STK17A in evaluating radiotherapy efficacy and their effects on cell migration and invasion via the p53 signaling pathway in cervical cancer.
Wei W; Liu C
Mol Med Rep; 2020 Jan; 21(1):267-281. PubMed ID: 31746360
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of anti-cancer effects by paclitaxel treatment in cervical cancer cells.
Lee KH; Yim EK; Kim CJ; Namkoong SE; Um SJ; Park JS
Gynecol Oncol; 2005 Jul; 98(1):45-53. PubMed ID: 15907983
[TBL] [Abstract][Full Text] [Related]
15. Activation of AIFM2 enhances apoptosis of human lung cancer cells undergoing toxicological stress.
Lu J; Chen J; Xu N; Wu J; Kang Y; Shen T; Kong H; Ma C; Cheng M; Shao Z; Xu L; Zhao X
Toxicol Lett; 2016 Sep; 258():227-236. PubMed ID: 27392435
[TBL] [Abstract][Full Text] [Related]
16. Paclitaxel combined with siRNA targeting HPV16 oncogenes improves cytotoxicity for cervical carcinoma.
Liu WL; Green N; Seymour LW; Stevenson M
Cancer Gene Ther; 2009 Oct; 16(10):764-75. PubMed ID: 19363466
[TBL] [Abstract][Full Text] [Related]
17. CircMYBL2 regulates the resistance of cervical cancer cells to paclitaxel via miR-665-dependent regulation of EGFR.
Dong M; Li P; Xie Y; Wang Z; Wang R
Drug Dev Res; 2021 Dec; 82(8):1193-1205. PubMed ID: 34046939
[TBL] [Abstract][Full Text] [Related]
18. CircGFRA1 facilitates the malignant progression of HER-2-positive breast cancer via acting as a sponge of miR-1228 and enhancing AIFM2 expression.
Bazhabayi M; Qiu X; Li X; Yang A; Wen W; Zhang X; Xiao X; He R; Liu P
J Cell Mol Med; 2021 Nov; 25(21):10248-10256. PubMed ID: 34668628
[TBL] [Abstract][Full Text] [Related]
19. FOXM1 Promotes Drug Resistance in Cervical Cancer Cells by Regulating ABCC5 Gene Transcription.
Hou Y; Dong Z; Zhong W; Yin L; Li X; Kuerban G; Huang H
Biomed Res Int; 2022; 2022():3032590. PubMed ID: 35141332
[TBL] [Abstract][Full Text] [Related]
20. Paclitaxel inhibits the progression of cervical cancer by inhibiting autophagy via lncRNARP11-381N20.2.
Zou SH; Du X; Lin H; Wang PC; Li M
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3010-3017. PubMed ID: 29863245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
